CCL24, CXCL9, and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac617
Abstract: OBJECTIVE Oligoarticular Juvenile Idiopathic Arthritis (JIA) disease progression and outcomes are variable. Our objective is to detect protein markers that would allow for earlier intervention to potentially halt disease progression. In this retrospective study of… read more here.
Keywords: advanced treatment; cxcl9 cxcl10; ccl24 cxcl9; synovial fluid ... See more keywords